FDA clears first therapy for rare childhood cancer
- OPACC
- Mar 11, 2015
- 1 min read
United Therapeutics' Unituxin has become the first-ever therapy approved in the US for neuroblastoma, a rare form of cancer that most commonly occurs in young children.
Comments